| pubmed-article:3092258 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3092258 | lifeskim:mentions | umls-concept:C0027983 | lld:lifeskim |
| pubmed-article:3092258 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:3092258 | lifeskim:mentions | umls-concept:C0010737 | lld:lifeskim |
| pubmed-article:3092258 | lifeskim:mentions | umls-concept:C1511632 | lld:lifeskim |
| pubmed-article:3092258 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:3092258 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:3092258 | pubmed:dateCreated | 1986-9-26 | lld:pubmed |
| pubmed-article:3092258 | pubmed:abstractText | The microfilament structures of Newcastle disease virus (NDV)-infected BHK-21 cells were studied in the presence (5 micrograms/ml) or absence of cytochalasin B (CB) by means of phase contrast, indirect immunofluorescence and thin-section immunoelectron microscopy. The results indicated that CB treatment not only impaired virus infections titers and antiactin fluorescence strength but also disrupted cytoplasmic membrane and untagged ferritin-conjugated antibody on the surface of NDV specific antigens. | lld:pubmed |
| pubmed-article:3092258 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3092258 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3092258 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3092258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3092258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3092258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3092258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3092258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3092258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3092258 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3092258 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:3092258 | pubmed:issn | 0255-6596 | lld:pubmed |
| pubmed-article:3092258 | pubmed:author | pubmed-author:WangD MDM | lld:pubmed |
| pubmed-article:3092258 | pubmed:author | pubmed-author:SoongM MMM | lld:pubmed |
| pubmed-article:3092258 | pubmed:author | pubmed-author:ChenW FWF | lld:pubmed |
| pubmed-article:3092258 | pubmed:author | pubmed-author:LiangS CSC | lld:pubmed |
| pubmed-article:3092258 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3092258 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:3092258 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3092258 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3092258 | pubmed:pagination | 137-44 | lld:pubmed |
| pubmed-article:3092258 | pubmed:dateRevised | 2008-2-26 | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:meshHeading | pubmed-meshheading:3092258-... | lld:pubmed |
| pubmed-article:3092258 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:3092258 | pubmed:articleTitle | Cytochalasin B changes the cytoskeletal organization in Newcastle disease virus-infected cells. | lld:pubmed |
| pubmed-article:3092258 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3092258 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3092258 | lld:pubmed |
